1 Min Read
Aug 31 (Reuters) - Vectus Biosystems Ltd
* FY revenues from ordinary activities down 35 percent to $49,000
* FY loss for period attributable to members $3.8 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.